Status:
COMPLETED
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Lead Sponsor:
Associazione Italiana Ematologia Oncologia Pediatrica
Conditions:
Leukemia
Eligibility:
All Genders
1-17 years
Phase:
PHASE3
Brief Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination c...
Detailed Description
OBJECTIVES: * Compare the relative efficacy of induction therapy comprising dexamethasone or prednisone, in terms of a higher rate of event-free survival (EFS) and overall survival and a reduced rate...
Eligibility Criteria
Inclusion
- Histologically confirmed acute lymphoblastic leukemia (ALL)
- No secondary ALL
- More than 4 weeks since prior chemotherapy
- More than 4 weeks since prior steroids
Exclusion
- Prior disease that would preclude treatment with chemotherapy
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
2039 Patients enrolled
Trial Details
Trial ID
NCT00613457
Start Date
September 1 2000
End Date
July 1 2006
Last Update
January 14 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.